Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection (original) (raw)

Clindamycin, Cephalosporins, Fluoroquinolones, and Clostridium difficile –Associated Diarrhea: This Is an Antimicrobial Resistance Problem

Dale Gerding

Clinical Infectious Diseases, 2004

View PDFchevron_right

Emergence and Control of Fluoroquinolone‐Resistant, Toxin A–Negative, Toxin B–Positive Clostridium difficile •

Margaret Hannan

Infection Control and Hospital Epidemiology, 2007

View PDFchevron_right

818 @BULLET CID 2008:47 (15 September) @BULLET BRIEF REPORT High Levels of Resistance to Fluoroquinolones among Clostridium difficile Isolates in a Spanish Hospital

mar ss

View PDFchevron_right

Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové

Roman Spanek

Antibiotics, 2021

View PDFchevron_right

A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use

Marian Pokrywka

Infection Control & Hospital Epidemiology, 2005

View PDFchevron_right

Evaluation of Clostridium difficile-Associated Diarrhea With a Drug Formulary Change in Preferred Fluoroquinolones

Roslyn Stone

2008

View PDFchevron_right

Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital

Riaz Khan

Journal of Hospital Infection, 2003

View PDFchevron_right

Antibiotic-associated diarrhoea and Clostridium difficile> in the community

Michel Cadilhac

Alimentary Pharmacology and Therapeutics, 2003

View PDFchevron_right

Poor Infection Control, Not Fluoroquinolones, Likely to Be Primary Cause of Clostridium difficile-Associated Diarrhea Outbreaks in Quebec

Karl Weiss

Clinical Infectious Diseases, 2006

View PDFchevron_right

Antimicrobial Agents and Clostridium difficile in Acute Enteric Disease: Epidemiological Data from Sweden, 1980-1982

Roland Möllby

Journal of Infectious Diseases, 1985

View PDFchevron_right

Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich

Orville Heslop

BMC Infectious Diseases, 2014

View PDFchevron_right

Clostridium difficile virulence factors as the cause of antibiotic-associated diarrhea (AAD): a literature review

Agus Darwinata

Bali Medical Journal, 2022

View PDFchevron_right

Risk factors for Clostridium difficile colonisation and toxin production

HEATHER MARTIN

Age and Ageing, 2003

View PDFchevron_right

Clostridium difficile 30 years on: what has, or has not, changed and why?

Dale Gerding

International Journal of Antimicrobial Agents, 2009

View PDFchevron_right

Fluoroquinolone Use and Risk Factors for Clostridium difficile-Associated Disease within a Veterans Administration Health Care System

HENRY BENEDA

Clinical Infectious Diseases, 2007

View PDFchevron_right

In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004

Dale Gerding

Antimicrobial Agents and Chemotherapy, 2007

View PDFchevron_right

2007. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the cecal contents of mice. Antimicrob. Agents Chemother

Curtis Donskey

2015

View PDFchevron_right

Clostridium difficile: A Growing Health Concern

Anindita Pal

Journal of Advanced Scientific Research, 2019

View PDFchevron_right

Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile

Dale Gerding

Journal of Hospital Infection, 2009

View PDFchevron_right

Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options

Saeed Nazeri

Scientifica, 2014

View PDFchevron_right

Temporal effects of antibiotic use and Clostridium difficile infections

Peter Davey

Journal of …, 2009

View PDFchevron_right

Corelations Between the Use of Medical Substances and the Incidence Infections Produced by Clostridium Difficile Species

Moldovan Cosmin

Revista de Chimie, 2018

View PDFchevron_right

Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile

Joseph Silva

Clinical Microbiology and Infection, 2003

View PDFchevron_right

Complete Restriction of Fluoroquinolone Use to Control an Outbreak of Clostridium difficile Infection at a Community Hospital

Ainsley Nicholson

Infection Control and Hospital Epidemiology, 2009

View PDFchevron_right

Effects of Exposure of Clostridium difficile PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model

Jane Freeman

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

Clostridium difficileinfection: update on emerging antibiotic treatment options and antibiotic resistance

Minh Đăng TMĐ

Expert Review of Anti-infective Therapy, 2010

View PDFchevron_right

Increased Incidence of Clostridium difficile-Associated Diarrhea Following Decreased Restriction of Antibiotic Use

Macy Ho

Clinical Infectious Diseases, 1996

View PDFchevron_right

Toxigenic Clostridium difficile isolates from clinically significant diarrhoea in patients from a tertiary care centre

Rakesh Kochhar

The Indian journal of medical research, 2017

View PDFchevron_right

Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile

Gilles Potel

Microbial Ecology, 2008

View PDFchevron_right

Barrier Effect of Normal Microbiota Against Clostridium difficile may be Influenced by Drugs Devoid of Antibiotic Activity

Tuomo Karjalainen

Microbial Ecology in Health and Disease, 1994

View PDFchevron_right

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

Sandra Dial

Canadian Medical Association Journal, 2008

View PDFchevron_right

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe

F. Barbut, Ian Poxton

Journal of Medical Microbiology, 2008

View PDFchevron_right

Susceptibility of hamsters to human pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration

Michelle Merrigan

Anaerobe, 2003

View PDFchevron_right

Spore Production of Toxigenic and Non-toxigenic Clostridium difficile Isolates in Sub-MIC of Vancomycin, Clindamycin, and Ceftazidime

mohammad moradi

Jundishapur Journal of Microbiology, 2019

View PDFchevron_right

Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo

Anne Collignon

Antimicrobial Agents and Chemotherapy, 1992

View PDFchevron_right